Should You Retain Teleflex Stock in Your Portfolio Right Now?

Teleflex’s (TFX) broad Vascular Access portfolio is poised to continue to win shares through its category leadership in Central Venous Catheters (CVC), midlines and new launches. The company’s expansion efforts into Asia bring promising long-term growth prospects. The Interventional arm is also driving solid growth through its key drivers, which is highly promising.  Meanwhile, the adverse impact of macroeconomic challenges and the competitive landscape remains a concern for Teleflex.In the past year, this ...